Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $3.6 million.

  • Solid Biosciences' Amortizatization of Intangibles fell 30.23% to $803,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.6 million, marking a year-over-year increase of 49.17%. This contributed to the annual value of $3.6 million for FY2024, which is 49.17% up from last year.
  • As of FY2024, Solid Biosciences' Amortizatization of Intangibles stood at $3.6 million, which was up 49.17% from $2.4 million recorded in FY2023.
  • Solid Biosciences' 5-year Amortizatization of Intangibles high stood at $3.6 million for FY2024, and its period low was -$1.1 million during FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $2.4 million (2023), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Solid Biosciences' Amortizatization of Intangibles plummeted by 5,685.00% in 2021, and later surged by 1,133.48% in 2023.
  • Solid Biosciences' Amortizatization of Intangibles (Yearly) stood at $20,000 in 2020, then plummeted by 5,685.00% to -$1.1 million in 2021, then skyrocketed by 79.14% to -$233,000 in 2022, then soared by 1,133.48% to $2.4 million in 2023, then surged by 49.17% to $3.6 million in 2024.